Probiotics and bone disorders: the role of RANKL/RANK/OPG pathway
N Amin, V Boccardi, M Taghizadeh… - Aging clinical and …, 2020 - Springer
The skeleton is the framework and in charge of body configuration preservation. As a living
tissue, bones are constantly being formed and absorbed. Osteoblasts and osteoclasts are …
tissue, bones are constantly being formed and absorbed. Osteoblasts and osteoclasts are …
Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches
A Fraldi, M Serafini, NC Sorrentino, B Gentner… - Italian journal of …, 2018 - Springer
Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by a
deficiency in lysosomal enzymes catalyzing the stepwise degradation of …
deficiency in lysosomal enzymes catalyzing the stepwise degradation of …
β2-Adrenergic signal transduction plays a detrimental role in subchondral bone loss of temporomandibular joint in osteoarthritis
K Jiao, LN Niu, Q Li, G Ren, C Zhao, Y Liu, FR Tay… - Scientific reports, 2015 - nature.com
The present study tested whether activation of the sympathetic tone by aberrant joint loading
elicits abnormal subchondral bone remodeling in temporomandibular joint (TMJ) …
elicits abnormal subchondral bone remodeling in temporomandibular joint (TMJ) …
[HTML][HTML] Mesenchymal stromal cells shape the MDS microenvironment by inducing suppressive monocytes that dampen NK cell function
Altered BM hematopoiesis and immune suppression are hallmarks of myelodysplastic
syndrome (MDS). While the BM microenvironment influences malignant hematopoiesis, the …
syndrome (MDS). While the BM microenvironment influences malignant hematopoiesis, the …
Bone marrow-derived mesenchymal stromal cells: a novel target to optimize hematopoietic stem cell transplantation protocols in hematological malignancies and rare …
S Crippa, L Santi, R Bosotti, G Porro… - Journal of Clinical …, 2019 - mdpi.com
Mesenchymal stromal cells (MSCs) are crucial elements in the bone marrow (BM) niche
where they provide physical support and secrete soluble factors to control and maintain …
where they provide physical support and secrete soluble factors to control and maintain …
[HTML][HTML] Osteoimmunology in mucopolysaccharidoses type I, II, VI and VII. Immunological regulation of the osteoarticular system in the course of metabolic …
V Opoka-Winiarska, A Jurecka, A Emeryk… - Osteoarthritis and …, 2013 - Elsevier
Summary Background Mucopolysaccharidoses (MPSs) are rare genetic diseases caused by
a deficient activity of one of the lysosomal enzymes involved in the glycosaminoglycan …
a deficient activity of one of the lysosomal enzymes involved in the glycosaminoglycan …
[HTML][HTML] Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells …
A Pievani, V Scagliotti, FM Russo, I Azario, B Rambaldi… - Cytotherapy, 2014 - Elsevier
Background aims Cord blood (CB) and amniotic fluid (AF) could represent new and
attractive mesenchymal stromal cell (MSC) sources, but their potential therapeutic …
attractive mesenchymal stromal cell (MSC) sources, but their potential therapeutic …
Immunosuppression does not affect human bone marrow mesenchymal stromal cell efficacy after transplantation in traumatized mice brain
The need for immunosuppression after allo/xenogenic mesenchymal stromal cell (MSC)
transplantation is debated. This study compared the long-term effects of human (h) bone …
transplantation is debated. This study compared the long-term effects of human (h) bone …
Extracellular matrix disruption is an early event in the pathogenesis of skeletal disease in mucopolysaccharidosis I
JM Heppner, F Zaucke, LA Clarke - Molecular genetics and metabolism, 2015 - Elsevier
Progressive skeletal and connective tissue disease represents a significant clinical burden
in all of the mucopolysaccharidoses. Despite the introduction of enzyme replacement …
in all of the mucopolysaccharidoses. Despite the introduction of enzyme replacement …
[HTML][HTML] Current and Future Perspective in Hematopoietic Stem Progenitor Cell-gene Therapy for Inborn Errors of Metabolism
F Tucci, G Consiglieri, M Cossutta, ME Bernardo - HemaSphere, 2023 - journals.lww.com
Inborn errors of metabolism (IEM) are a group of rare, heterogenous diseases caused mostly
by monogenic mutations that result in disruption of metabolic pathways due to deficient …
by monogenic mutations that result in disruption of metabolic pathways due to deficient …